Showing 266 Results
The Impact of Comparative Effectiveness Research on Health and Health Care Spending
Although health care stakeholders acknowledge that health care treatments can affect different segments of the patient population in different ways, early discussions focused on how comparative…
Employer Medication Adherence, Comorbidities, and Health Risk Impacts on Workforce Absence and Job Performance
While medication adherence is a critical element in reducing the impact of illness, employers should view it as just one of multiple components that are needed in strategic employee disease…
The Productivity Crisis in Pharmaceutical R&D
Advances in the understanding of the molecular basis of diseases have expanded the number of plausible therapeutic targets for the development of innovative agents in recent decades. However,…
The State of Comparative Effectiveness Research and the Environment for Decision-Making (2011)
Comparative effectiveness research (CER) has gained in national prominence in recent years through an infusion of federal funds and passage of the Patient Protection and Affordable Care Act (PPACA),…
Synergies at Work: Realizing the Full Value of Health Investment
According to this NPC-sponsored research, employers need a sound understanding of the value that a healthy employee population brings to their businesses. Synergies at Work: Realizing the Full Value…
The Patient-Centered Outcomes Research Institute Methodology Committee: Resource Guide
In March 2010, President Obama signed into law the Patient Protection and Affordable Care Act, broad health reform legislation that established the Patient-Centered Outcomes Research Institute (PCORI…
International Comparison of Comparative Effectiveness Research in Five Jurisdictions: Insights for the US
This article, published in the Ocotber 2010 issue of PharmacoEconomics, examines health technology assessments (HTA) in Canada, Sweden, Scotland, The Netherlands and Australia and identifies seven…
The Patient-Centered Outcomes Research Institute Resource Guide
A key provision of the Patient Protection and Affordable Care Act, the health reform legislation signed into law in March 2010, establishes the Patient Centered Outcomes Research Institute (PCORI), a…
Value in Health Special Issue: Apples and Oranges? Assessing Comparative Effectiveness and Comparative Value in the U.S. and Other Countries
This special issue of Value in Health showcases presentations made at the Apples and Oranges? Assessing Comparative Effectiveness and Comparative Value in the U.S. and Other Countries symposium held…
Value-Based Insurance Design Toolkit
Employers throughout the country are increasingly concerned with improving the health and productivity of their workforces, while maximizing the value of the health care services provided. This…
Comparative Effectiveness Research Toolkit
The establishment of the nonprofit, public-private entity, the Patient-Centered Outcomes Research Institute (PCORI), in the new health reform law has elevated the visibility and importance of…
Comparative Effectiveness Research Informational Series
Although the concept of comparative effectiveness research (CER) is not new, it is important to establish a clear definition and understanding of why it is so prominent today and the many related…
Good ReseArch for Comparative Effectiveness (GRACE) Initiative
The growth in therapeutic choices for many conditions has sparked interest in evaluating the comparative effectiveness of these alternatives. Randomized clinical trials frequently do not provide…
Demystifying Comparative Effectiveness Research: A Case Study Learning Guide
This report, “Demystifying Comparative Effectiveness Research: A Case Study Learning Guide,” written by Robert W. Dubois, MD, PhD, chief medical officer of Cerner LifeSciences, and Sylvia L…
Demystifying Comparative Effectiveness Research: A Case Study Learning Guide (Executive Summary)
This 16-page executive summary of the report, Demystifying Comparative Effectiveness Research: A Case Study Learning Guide, written by Robert W. Dubois, MD, PhD, then chief medical officer of Cerner…
Framing the Debate- Untangling the Potential Impact of Comparative Effectiveness Research on Innovation
Investment in comparative effectiveness research (CER) -- including $1.1 billion of new federal funding appropriated in the American Reinvestment and Recovery Act and the creation of the Patient…
Employer Medication Compliance Initiatives: Executive Summary
This study, which for the first time surveyed employers’ views and strategies on medication compliance, says 89% of employers acknowledge its importance to employee health.
Health Plan Capabilities to Support Value Based Benefit Design
This guide around health plan capabilities to support Value Based Benefit Design is meant to assist employers in understanding how to more effectively work with their health plans to implement…
Resources for Medicare Beneficiaries: Using Your Medicare Drug Plan | What to Do If Your Medicine Isn’t Covered
This 12-page publication helps Medicare Part D recipients and caregivers understand some of the challenges involved in navigating the Medicare prescription drug system.